Severe Extra-articular Disease Manifestations Are Associated with an Increased Risk of First Ever Cardiovascular Events in Patients with Rheumatoid Arthritis

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2006 Aug 1

PMID 16877533

Citations 52

Authors

C Turesson

R L McClelland

T J H Christianson

E L Matteson

Affiliations

Soon will be listed here.

Abstract

Background: Rheumatoid arthritis is associated with increased cardiovascular mortality and morbidity.

Objective: To assess the effect of severe extra-articular rheumatoid arthritis (ExRA) manifestations on the risk of cardiovascular disease (CVD) in patients with rheumatoid arthritis.

Methods: Patients with ExRA (n = 81) according to predefined criteria and controls (n = 184) without evidence of extra-articular disease were identified from a large research database of patients with rheumatoid arthritis. In a structured review of the medical records, the occurrence and the date of onset of clinically diagnosed CVD events were noted. Cox proportional hazards models were used to estimate the effect of ExRA on the risk of first ever CVD events after the diagnosis of rheumatoid arthritis. ExRA manifestations were modelled as time-dependent covariates, with adjustment for age, sex and smoking at the diagnosis of rheumatoid arthritis. Onset of erosive disease and rheumatoid factor seropositivity were entered as time-dependent variables. Patients were followed until onset of CVD, death or loss to follow-up.

Results: ExRA was associated with a significantly increased risk of first ever CVD events (p<0.001), and also with an increased risk of new-onset coronary artery disease, adjusted for age, sex and smoking (hazard ratio (HR): 3.16; 95% confidence interval (95% CI: 1.58 to 6.33). The association between ExRA and any first ever CVD event remained significant when controlling for age, sex, smoking, rheumatoid factor and erosive disease (HR: 3.25; 95% CI: 1.59 to 6.64).

Conclusion: Severe ExRA manifestations are associated with an increased risk of CVD events in patients with rheumatoid arthritis. This association is not due to differences in age, sex, smoking, rheumatoid factor or erosive joint damage. It is suggested that systemic extra-articular disease is a major determinant of cardiovascular morbidity in rheumatoid arthritis.

Citing Articles

The effect of long-term traditional Chinese medicine treatment on extra-articular lesions of rheumatoid arthritis patients based on propensity score matching: A retrospective cohort study.

Wen J, Liu J, Wan L, Xin L, Sun Y, Wang F Heliyon. 2024; 10(1):e23147.

PMID: 38187299 PMC: 10770526. DOI: 10.1016/j.heliyon.2023.e23147.

Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis.

Luciano N, Barone E, Timilsina S, Gershwin M, Selmi C Clin Rev Allergy Immunol. 2023; 65(3):403-419.

PMID: 38157095 DOI: 10.1007/s12016-023-08975-z.

Systematic review of associations between concomitant rheumatoid arthritis and peripheral arterial disease, health-related quality of life and functional capacity.

Zoubi T, Gordon H Rheumatol Int. 2022; 43(2):221-232.

PMID: 36449056 PMC: 9898339. DOI: 10.1007/s00296-022-05245-7.

Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis.

Giachi A, Cugno M, Gualtierotti R Front Cardiovasc Med. 2022; 9:1012661.

PMID: 36352850 PMC: 9637771. DOI: 10.3389/fcvm.2022.1012661.

The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.

Muhammed H, Misra D, Jain N, Ganguly S, Pattanaik S, Rai M Clin Rheumatol. 2022; 41(12):3675-3686.

PMID: 36006556 DOI: 10.1007/s10067-022-06349-y.

References

Wallberg-Jonsson S, Johansson H, Ohman M, Rantapaa-Dahlqvist S . Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol. 1999; 26(12):2562-71. View

Foster C, Forstot S, Wilson L . Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. 1984; 91(10):1253-63. DOI: 10.1016/s0161-6420(84)34160-4. View

Turesson C, Jacobsson L, Bergstrom U, Truedsson L, Sturfelt G . Predictors of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2000; 29(6):358-64. DOI: 10.1080/030097400447552. View

del Rincon I, Williams K, Stern M, Freeman G, Escalante A . High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2002; 44(12):2737-45. DOI: 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-%23. View

Turesson C, OFallon W, Crowson C, Gabriel S, Matteson E . Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol. 2002; 29(1):62-7. View

Goodson N, Wiles N, Lunt M, Barrett E, Silman A, Symmons D . Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum. 2002; 46(8):2010-9. DOI: 10.1002/art.10419. View

Doran M, Crowson C, Pond G, OFallon W, Gabriel S . Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002; 46(9):2294-300. DOI: 10.1002/art.10529. View

Mikuls T, Saag K, Criswell L, Merlino L, Kaslow R, Shelton B . Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study. Ann Rheum Dis. 2002; 61(11):994-9. PMC: 1753931. DOI: 10.1136/ard.61.11.994. View

Gabriel S, Crowson C, Kremers H, Doran M, Turesson C, OFallon W . Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003; 48(1):54-8. DOI: 10.1002/art.10705. View

10.

Solomon D, Karlson E, Rimm E, Cannuscio C, Mandl L, Manson J . Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003; 107(9):1303-7. DOI: 10.1161/01.cir.0000054612.26458.b2. View

11.

Turesson C, OFallon W, Crowson C, Gabriel S, Matteson E . Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003; 62(8):722-7. PMC: 1754626. DOI: 10.1136/ard.62.8.722. View

12.

Goronzy J, Weyand C . Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther. 2003; 5(5):225-34. PMC: 193735. DOI: 10.1186/ar974. View

13.

Engstrom G, Stavenow L, Hedblad B, Lind P, Tyden P, Janzon L . Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk. Arterioscler Thromb Vasc Biol. 2003; 23(12):2247-51. DOI: 10.1161/01.ATV.0000102924.11767.8D. View

14.

Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-24. DOI: 10.1002/art.1780310302. View

15.

Erhardt C, Mumford P, Venables P, Maini R . Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis. 1989; 48(1):7-13. PMC: 1003667. DOI: 10.1136/ard.48.1.7. View

16.

Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C . Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336(14):973-9. DOI: 10.1056/NEJM199704033361401. View

17.

van der Vliet J, Boll A . Abdominal aortic aneurysm. Lancet. 1997; 349(9055):863-6. DOI: 10.1016/s0140-6736(96)07282-0. View

18.

Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C . Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998; 97(5):425-8. DOI: 10.1161/01.cir.97.5.425. View

19.

Ridker P, Buring J, Shih J, Matias M, Hennekens C . Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998; 98(8):731-3. DOI: 10.1161/01.cir.98.8.731. View

20.

Turesson C, Jacobsson L, Bergstrom U . Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999; 38(7):668-74. DOI: 10.1093/rheumatology/38.7.668. View